Resources
About Us
Home Report
Store
Latin America NGS Market
Latin America NGS Market by Offering (Kits [Library Prep, QC, DNA Extraction], System) Type (Genome, Exome, Targeted) Application (Reproductive, Oncology, Infectious, Drug Discovery) Technology (SBS, Nanopore, Nanoball, SMRT Seq, DNB) – Forecast to 2031
Report ID:MRHC - 1041097 Pages: 170 Feb-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 HoursThe Latin America NGS Market was valued at $273.2 million in 2023. This market is expected to reach $765.2 million by 2031, from an estimated $307.7 million in 2024, at a CAGR of 13.9% during the forecast period 2024-2031.
Latin America NGS Market Size & Forecast
The speed, throughput, and accuracy of Next-Generation Sequencing (NGS) have revolutionized genetic analysis, enabling its use in various applications. NGS technology has found applications in genomic and clinical research, reproductive health, and environmental, agricultural, and forensic science. It has the potential to become the ultimate genotyping platform for human identification. The capabilities of NGS extend to forensic markers, including short tandem repeats (STR) and mitochondrial and Y-chromosome haplotypes. The decreasing cost of sequencing per base, along with the introduction of cost-effective benchtop laboratory sequencers, has driven the incorporation of discrete NGS data within the clinical arena for personalized medicine.
The growth of the Latin America NGS market can be attributed to various factors, including the increasing initiatives by governments and organizations for genomic sequencing projects, advancements in sequencing procedures, decreasing costs of genome sequencing, a rise in cancer prevalence, and the expanding application of NGS in cancer treatment and research. However, the high costs of NGS systems and consumables and the availability of alternative technologies restrain the market's growth.
The rising adoption of bioinformatics and genomic data management solutions, as well as collaborations and partnerships to support next-generation sequencing, are expected to create market growth opportunities. However, the lack of skilled professionals and ethical and legal issues related to NGS-based diagnosis pose a significant challenge to the market's growth.
Click here to: Get Free Sample Pages of this Report
Increasing Initiatives by Governments and Organizations for Genomic Sequencing Projects, Driving the Market's Growth
With rapid advancements in NGS technology, various organizations & governments are actively undertaking initiatives for genomic sequencing projects. These initiatives aim to improve early disease diagnosis. Some of the initiatives are as follows:
-
In March 2023, MGI Tech Co., Ltd. (China) collaborated with Pensabio (Brazil) to assist a massive national genomic sequencing initiative using a sequencer. The objective of the project was to sequence the entire genomes of thousands of patients with hereditary cancers and rare diseases, search for genetic markers to monitor inherited diseases for early diagnosis, and stimulate technological advances and scientific development in the country by improving the growth of the Brazilian genomic industry.
- In December 2022, the oriGen project was launched to analyze the genomes of over 10,000 Mexicans. This initiative is a collaboration among several genomic leaders with the goal of improving precision and preventative healthcare in Mexico.
Collaborations and Partnerships to Support Next-Generation Sequencing, Creating Market Growth Opportunities
Next Generation Sequencing (NGS) is a technology used to sequence the orientation of nucleotides in genetic material. This technology enables the sequencing of DNA or RNA more quickly and at a lower cost compared to Sanger sequencing. Continuous developments in NGS technology are revolutionizing the field of personalized medicine, genetic diseases, and clinical diagnostics by providing the capability to sequence multiple individuals with a variable genetic orientation simultaneously. Various organizations are focusing on partnerships, collaborations, and expansion to increase genetic testing and support next-generation sequencing. For instance:
- In January 2024, SOPHiA GENETICS (Switzerland) collaborated with Bioma4me (Brazil) to support genetic testing in Brazil. Under this collaboration, the company will leverage SOPHiA GENETICS' technology to enhance and simplify its genetic testing capabilities.
- In March 2023, SOPHiA GENETICS (Switzerland) partnered with Qiagen N.V. (Netherlands) to pair QIAseq reagent technology with the SOPHiA DDM platform to improve tumor analysis through next-generation sequencing (NGS).
- In April 2022, Illumina, Inc. (U.S.) expanded its new solution center in São Paulo, Brazil. This facility helps to fulfill the increasing demand and interest in clinical genomics and expand global access to genomics in Latin America.
Key Findings in the Latin America NGS Market Study:
Consumables Segment to Account for the Largest Share of the Market in 2024
Among the offerings, in 2024, the consumables segment is expected to account for the largest share of the Latin America NGS market. The recurring use of consumables, rising demand for NGS-based diagnostic tests, and increasing applications of NGS in oncology, reproductive health diagnosis, and drug discovery are increasing the demand for consumables, contributing to the large market share of this segment.
Targeted Genome Sequencing Segment to Account for the Largest Share of the Market in 2024
Among sequencing types, in 2024, the targeted genome sequencing segment is expected to account for the largest share of the Latin America NGS market. Targeted genome sequencing significantly reduces the cost per sample over whole genome shotgun sequencing by enabling sequencing of only the desired regions of a genome. Furthermore, the early success of targeted sequencing methods has created a rapidly growing demand for targeted sequencing in areas such as cancer, human genetic disease, and the validation of genome-wide association studies. These factors have increased the adoption of targeted genome sequencing, contributing to the large market share of this segment.
Sequencing by Synthesis Segment to Account for the Largest Share of the Market in 2024
Among the technologies, in 2024, the sequencing by synthesis segment is expected to account for the largest share of the Latin America NGS market. The large share of this segment is primarily attributed to the high accuracy of this technology in DNA sequencing, its highest yield of error-free throughput, and the increasing incorporation of this technology in NGS products.
Research Applications Segment to Account for the Largest Share of the Market in 2024
Among the applications, in 2024, the research applications segment is expected to account for the largest share of the Latin America NGS market. The large market share of this segment is attributed to the rising adoption of sequencing-based tests in laboratories, the growth in NGS-based research activities, and the increasing collaborations between market players in research programs for personalized medicine and genetic testing. For instance, in May 2023, BGI Genomics Co., Ltd. (China) collaborated with Universidad Mayor (Chile) to provide full NGS solutions comprising sequencing platforms and other equipment to support the university's precision oncology center. Similarly, BGI Genomics Co., Ltd. (China) signed an agreement with Biocódices SA (Argentina) to deliver advanced noninvasive prenatal genetic testing technologies, with the goal of reducing the cost of NIPT for Argentine consumers.
Pharmaceutical & Biotechnology Companies Segment to Account for the Largest Share of the Latin America NGS Market in 2024
Among the end users, in 2024, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the Latin America NGS market. The large market share of this segment is attributed to factors such as the increasing adoption of advanced technologies for research purposes, increasing research for drug discovery with widening NGS applications, and the rising incidence of chronic diseases. For instance, according to GLOBOCAN, in 2020, 592,212 people were diagnosed with cancer in Brazil. This number is projected to reach 786,686 by 2030. Additionally, in 2020, 195,499 people were diagnosed with cancer in Mexico. This number is projected to reach 254,665 by 2030.
Brazil to Account for the Largest Market Share in 2024
In 2024, Brazil is expected to account for the largest share of the Latin America NGS market. Brazil’s significant market share can be attributed to the rising healthcare expenditure, rising cancer cases,
growing adoption of NGS technology among healthcare professionals for the treatment of diseases, and an increasing number of sequencing projects such as the Brazilian Initiative on Precision Medicine (BIPMed), The ZiBRA project, and DNA do Brasil (DNABr).
Latin America NGS Market: Key Players
The report includes a competitive landscape based on an extensive assessment of the key growth strategies adopted by leading market players over the past three to four years. The key players profiled in the Latin America NGS market report are Thermo Fisher Scientific Inc. (U.S.), Illumina, Inc. (U.S.), Qiagen N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), PerkinElmer, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), and 10X Genomics, Inc. (U.S.).
Latin America NGS Market Report Summary:
|
Particulars |
Details |
|
Number of Pages |
170 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
13.9% |
|
Estimated Market Size (Value) |
$765.2 million by 2031 |
|
Segments Covered |
By Offering
By Sequencing Type
By Technology
By Application
By End User
|
|
Countries Covered |
Latin America (Brazil, Mexico, Argentina, Chile, and Rest of Latin America) |
|
Key Companies |
Thermo Fisher Scientific Inc. (U.S.), Illumina, Inc. (U.S.), Qiagen N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), PerkinElmer, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), and 10X Genomics, Inc. (U.S.). |
Key questions answered in the report:
This study offers a detailed assessment of the Latin America NGS market, including the market sizes and forecasts for various segmentations like offering, sequencing type, technology, application, and end user. This report also involves the value analysis of various segments and sub-segments of NGS at the country level.
The Latin America NGS market is projected to reach $765.2 million by 2031, at a CAGR of 13.9% during the forecast period.
Among the offerings, in 2024, the consumables segment is expected to account for the largest share of the Latin America NGS market. The large market share of this segment is attributed to the recurring use of consumables, rising demand for NGS-based diagnostic tests, and the increasing applications of NGS in oncology, reproductive health diagnosis, and drug discovery.
In 2024, the targeted genome sequencing segment is expected to account for the largest share of the Latin America NGS market. The large market share of this segment is attributed to its low sequencing costs compared to other sequencing technologies, increased sensitivity in variant calling, and advancements in targeted genome sequencing technologies.
The growth of the Latin America NGS market can be attributed to various factors, including the increasing initiatives by governments and organizations for genomic sequencing projects, advancements in sequencing procedures, decreasing costs of genome sequencing, a rise in cancer prevalence, and the expanding application of NGS in cancer treatment and research.
The rising adoption of bioinformatics and genomic data management solutions, as well as collaborations and partnerships to support next-generation sequencing, are expected to create market growth opportunities.
The key players profiled in the Latin America NGS market report are Thermo Fisher Scientific Inc. (U.S.), Illumina, Inc. (U.S.), Qiagen N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), PerkinElmer, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), and 10X Genomics, Inc. (U.S.).
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing & Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Growing Government Initiatives for Genomic Sequencing Projects
4.2.2. Technological Advancements in Sequencing Procedures
4.2.3. Declining Costs of Genome Sequencing
4.2.4. Rising Cancer Prevalence and Increasing Application of NGS in Cancer Treatment and Research
4.3. Restraints
4.3.1. High Costs of NGS Systems and Consumables
4.3.2. Availability of Alternative Technologies
4.4. Opportunities
4.4.1. Partnerships and Collaboration to Support Next-Generation Sequencing
4.4.2. Rising Adoption of Bioinformatics and Genomic Data Management Solutions
4.5. Challenges
4.5.1. Lack of Skilled Professionals
4.5.2. Ethical & Legal Issues Related to NGS-Based Diagnosis
4.6. Factor Analysis
4.7. Pricing Analysis
4.8. Regulatory Analysis
4.9. Adjacent Market Analysis
5. Latin America NGS Market Assessment—by Offering
5.1. Overview
5.2. Consumables
5.2.1. Sample Preparation Consumables
5.2.1.1. DNA Extraction and Amplification
5.2.1.2. Library Preparation & Target Enrichment
5.2.1.3. Quality Control
5.2.2. Other Consumables
5.3. NGS Platforms/Instruments
5.4. Software
5.5. Services
6. Latin America NGS Market Assessment—by Sequencing Type
6.1. Overview
6.2. Targeted Genome Sequencing
6.3. Whole Genome Sequencing
6.4. Whole Exome Sequencing
6.5. Other Sequencing Types
7. Latin America NGS Market Assessment—by Technology
7.1. Overview
7.2. Sequencing by Synthesis
7.3. Ion Semiconductor Sequencing
7.4. Single-molecule Real-time Sequencing (SMRT)
7.5. Nanopore Sequencing
7.6. DNA nanoball Sequencing
8. Latin America NGS Market Assessment—by Application
8.1. Overview
8.2. Research Applications
8.2.1. Drug Discovery
8.2.2. Agriculture & Animal Research
8.2.3. Other Research Applications
8.3. Clinical Applications
8.3.1. Reproductive Health
8.3.2. Oncology
8.3.3. Infectious Diseases
8.3.4. Other Clinical Applications
9. Latin America NGS Market Assessment—by End User
9.1. Overview
9.2. Pharmaceutical & Biotechnology Companies
9.3. Hospitals and Diagnostic Laboratories
9.4. Academic Institutes and Research Centers
9.5. Other End Users
10. Latin America NGS Market Assessment—by Country
10.1. Overview
10.2. Brazil
10.3. Mexico
10.4. Argentina
10.5. Chile
10.6. Rest of Latin America
11. Competition Analysis
11.1. Overview
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Competitive Dashboard
11.4.1. Industry Leaders
11.4.2. Market Differentiators
11.4.3. Vanguards
11.4.4. Emerging Companies
11.5. Market Share Analysis/Market Rankings, By Key Players (2023)
12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
12.1. Thermo Fisher Scientific Inc.
12.2. Illumina, Inc.
12.3. Qiagen N.V.
12.4. F. Hoffmann-La Roche Ltd.
12.5. PerkinElmer, Inc.
12.6. Agilent Technologies, Inc.
12.7. Danaher Corporation
12.8. Bio-Rad Laboratories, Inc.
12.9. Oxford Nanopore Technologies Plc.
12.10. 10X Genomics, Inc.
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
13. Appendix
13.1. Available Customization
13.2. Related Reports
List of Tables
Table 1 Latin America NGS Market, by Offering, 2022–2031 (USD Million)
Table 2 Latin America NGS Consumables Market, by Type, 2022–2031 (USD Million)
Table 3 Latin America NGS Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Latin America NGS Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 5 Latin America NGS Sample Preparation Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 6 Latin America NGS DNA Extraction and Amplification Market, by Country/Region, 2022–2031 (USD Million)
Table 7 Latin America NGS Library Preparation & Target Enrichment Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Latin America NGS Quality Control Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Latin America NGS Other Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Latin America NGS Platforms/Instruments Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Latin America NGS Software Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Latin America NGS Services Market, by Country/Region, 2022–2031 (USD Million)
Table 13 Latin America NGS Market, by Sequencing Type, 2022–2031 (USD Million)
Table 14 Latin America NGS Market for Targeted Genome Sequencing, by Country/Region, 2022–2031 (USD Million)
Table 15 Latin America NGS Market for Whole Genome Sequencing, by Country/Region, 2022–2031 (USD Million)
Table 16 Latin America NGS Market for Whole Exome Sequencing, by Country/Region, 2022–2031 (USD Million)
Table 17 Latin America NGS Market for Other Sequencing Types, by Country/Region, 2022–2031 (USD Million)
Table 18 Latin America NGS Market, by Technology, 2022–2031 (USD Million)
Table 19 Latin America NGS Market for Sequencing by Synthesis, by Country/Region, 2022–2031 (USD Million)
Table 20 Latin America NGS Market for Ion Semiconductor Sequencing, by Country/Region, 2022–2031 (USD Million)
Table 21 Latin America NGS Market for Single-molecule Real-time Sequencing (SMRT), by Country/Region, 2022–2031 (USD Million)
Table 22 Latin America NGS Market for Nanopore Sequencing, by Country/Region, 2022–2031 (USD Million)
Table 23 Latin America NGS Market for DNA nanoball sequencing, by Country/Region, 2022–2031 (USD Million)
Table 24 Latin America NGS Market, by Application, 2022–2031 (USD Million)
Table 25 Latin America NGS Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 26 Latin America NGS Market for Research Applications, by Country/Region, 2022–2031 (USD Million)
Table 27 Latin America NGS Market for Drug Discovery, by Country/Region, 2022–2031 (USD Million)
Table 28 Latin America NGS Market for Agriculture & Animal Research, by Country/Region, 2022–2031 (USD Million)
Table 29 Latin America NGS Market for Other Research Applications, by Country/Region, 2022–2031 (USD Million)
Table 30 Latin America NGS Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 31 Latin America NGS Market for Reproductive Health Diagnosis, by Country/Region, 2022–2031 (USD Million)
Table 32 Latin America NGS Market for Oncology, by Country/Region, 2022–2031 (USD Million)
Table 33 Latin America NGS Market for Infectious Diseases, by Country/Region, 2022–2031 (USD Million)
Table 34 Latin America NGS Market for Other Clinical Applications, by Country/Region, 2022–2031 (USD Million)
Table 35 Latin America: NGS Market, by End User, 2022–2031 (USD Million)
Table 36 Latin America NGS Market for Hospitals and Diagnostic Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 37 Latin America NGS Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022–2031 (USD Million)
Table 38 Latin America NGS Market for Academic Institutes & Research Centers, by Country/Region, 2022–2031 (USD Million)
Table 39 Latin America NGS Market for Other End Users, by Country/Region, 2022–2031 (USD Million)
Table 40 Latin America: NGS Market, by Country/Region, 2022–2031 (USD Million)
Table 41 Brazil: NGS Market, by Offering, 2022–2031 (USD Million)
Table 42 Brazil: NGS Consumables Market, by Type, 2022–2031 (USD Million)
Table 43 Brazil: NGS Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 44 Brazil: NGS Market, by Sequencing Type, 2022–2031 (USD Million)
Table 45 Brazil: NGS Market, by Technology, 2022–2031 (USD Million)
Table 46 Brazil: NGS Market, by Application, 2022–2031 (USD Million)
Table 47 Brazil: NGS Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 48 Brazil: NGS Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 49 Brazil: NGS Market, by End User, 2022–2031 (USD Million)
Table 50 Mexico: NGS Market, by Offering, 2022–2031 (USD Million)
Table 51 Mexico: NGS Consumables Market, by Type, 2022–2031 (USD Million)
Table 52 Mexico: NGS Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 53 Mexico: NGS Market, by Sequencing Type, 2022–2031 (USD Million)
Table 54 Mexico: NGS Market, by Technology, 2022–2031 (USD Million)
Table 55 Mexico: NGS Market, by Application, 2022–2031 (USD Million)
Table 56 Mexico: NGS Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 57 Mexico: NGS Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 58 Mexico: NGS Market, by End User, 2022–2031 (USD Million)
Table 59 Argentina: NGS Market, by Offering, 2022–2031 (USD Million)
Table 60 Argentina: NGS Consumables Market, by Type, 2022–2031 (USD Million)
Table 61 Argentina: NGS Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 62 Argentina: NGS Market, by Sequencing Type, 2022–2031 (USD Million)
Table 63 Argentina: NGS Market, by Technology, 2022–2031 (USD Million)
Table 64 Argentina: NGS Market, by Application, 2022–2031 (USD Million)
Table 65 Argentina: NGS Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 66 Argentina: NGS Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 67 Argentina: NGS Market, by End User, 2022–2031 (USD Million)
Table 68 Chile: NGS Market, by Offering, 2022–2031 (USD Million)
Table 69 Chile: NGS Consumables Market, by Type, 2022–2031 (USD Million)
Table 70 Chile: NGS Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 71 Chile: NGS Market, by Sequencing Type, 2022–2031 (USD Million)
Table 72 Chile: NGS Market, by Technology, 2022–2031 (USD Million)
Table 73 Chile: NGS Market, by Application, 2022–2031 (USD Million)
Table 74 Chile: NGS Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 75 Chile: NGS Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 76 Chile: NGS Market, by End User, 2022–2031 (USD Million)
Table 77 Rest of Latin America: NGS Market, by Offering, 2022–2031 (USD Million)
Table 78 Rest of Latin America: NGS Consumables Market, by Type, 2022–2031 (USD Million)
Table 79 Rest of Latin America: NGS Sample Preparation Consumables Market, by Type, 2022–2031 (USD Million)
Table 80 Rest of Latin America: NGS Market, by Sequencing Type, 2022–2031 (USD Million)
Table 81 Rest of Latin America: NGS Market, by Technology, 2022–2031 (USD Million)
Table 82 Rest of Latin America: NGS Market, by Application, 2022–2031 (USD Million)
Table 83 Rest of Latin America: NGS Market for Clinical Applications, by Type, 2022–2031 (USD Million)
Table 84 Rest of Latin America: NGS Market for Research Applications, by Type, 2022–2031 (USD Million)
Table 85 Rest of Latin America: NGS Market, by End User, 2022–2031 (USD Million)
Table 86 Recent Developments, by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Latin America NGS Market, by Offering, 2024 VS.2031 (USD Million)
Figure 8 Latin America NGS Market, by Sequencing Type, 2024 VS.2031 (USD Million)
Figure 9 Latin America NGS Market, by Technology, 2024 VS.2031 (USD Million)
Figure 10 Latin America NGS Market, by Application, 2024 VS.2031 (USD Million)
Figure 11 Latin America NGS Market, by End User, 2024 VS.2031 (USD Million)
Figure 12 Latin America NGS Market, by Country/Region
Figure 13 Impact Analysis: Latin America NGS Market
Figure 14 Latin America NGS Market, by Offering, 2024 VS.2031 (USD Million)
Figure 15 Latin America NGS Market, by Sequencing Type, 2024 VS.2031 (USD Million)
Figure 16 Latin America NGS Market, by Technology, 2024 VS.2031 (USD Million)
Figure 17 Latin America NGS Market, by Application, 2024 VS.2031 (USD Million)
Figure 18 Latin America NGS Market, by End User, 2024 VS.2031 (USD Million)
Figure 19 Latin America NGS Market, by Country/Region, 2024 VS.2031 (USD Million)
Figure 20 Latin America NGS Market Snapshot
Figure 21 Key Growth Strategies Adopted by Leading Players (2020–2024)
Figure 22 Latin America NGS Market: Vendor Dashboard
Figure 23 Latin America NGS Market: Competitive Benchmarking, by Offering
Figure 24 Latin America NGS Market: Competitive Benchmarking, by Sequencing Type
Figure 25 Market Share Analysis: Latin America NGS Market (2023)
Figure 26 Thermo Fisher Scientific, Inc.: Financial Snapshot, 2023
Figure 27 Illumina, Inc.: Financial Snapshot, 2023
Figure 28 Qiagen N.V.: Financial Snapshot, 2023
Figure 29 F. Hoffmann-La Roche Ltd: Financial Snapshot, 2023
Figure 30 PerkinElmer, Inc.: Financial Snapshot, 2023
Figure 31 Agilent Technologies, Inc.: Financial Snapshot, 2023
Figure 32 Pacific Biosciences of California, Inc.: Financial Snapshot, 2023
Figure 33 Danaher Corporation: Financial Snapshot, 2023
Figure 34 Oxford Nanopore Technologies Plc.: Financial Snapshot, 2023
Figure 35 10X Genomics, Inc.: Financial Snapshot, 2023
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Latin America Livestock Diagnostics Market - Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jul-2024
Latin America Telehealth Market - Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jul-2024
North America NGS Market - Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jul-2024
Latin America Molecular Diagnostics Market - Opportunity Analysis and Industry Forecasts (2024-2031)
Published Date: Jan-2024
Latin America IVD Market - Opportunity Analysis and Industry Forecast (2023-2030)
Published Date: Jul-2023
